These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 15380211)

  • 1. Benzopyranones with retro-amide side chains as (inhibitory) beta-lactamase substrates.
    Adediran SA; Cabaret D; Lohier JF; Wakselman M; Pratt RF
    Bioorg Med Chem Lett; 2004 Oct; 14(20):5117-20. PubMed ID: 15380211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and reactivity with beta-lactamases of a monobactam bearing a retro-amide side chain.
    Adediran SA; Lohier JF; Cabaret D; Wakselman M; Pratt RF
    Bioorg Med Chem Lett; 2006 Feb; 16(4):869-71. PubMed ID: 16300942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New substrates for beta-lactam-recognizing enzymes: aryl malonamates.
    Cabaret D; Adediran SA; Pratt RF; Wakselman M
    Biochemistry; 2003 Jun; 42(22):6719-25. PubMed ID: 12779326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The D-methyl group in beta-lactamase evolution: evidence from the Y221G and GC1 mutants of the class C beta-lactamase of Enterobacter cloacae P99.
    Adediran SA; Zhang Z; Nukaga M; Palzkill T; Pratt RF
    Biochemistry; 2005 May; 44(20):7543-52. PubMed ID: 15895997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the importance of a methyl group in beta-lactamase evolution: free energy profiles and molecular modeling.
    Bernstein NJ; Pratt RF
    Biochemistry; 1999 Aug; 38(32):10499-510. PubMed ID: 10441146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-secondary and solvent deuterium kinetic isotope effects on beta-lactamase catalysis.
    Adediran SA; Deraniyagala SA; Xu Y; Pratt RF
    Biochemistry; 1996 Mar; 35(11):3604-13. PubMed ID: 8639512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 4-Substituted trinems as broad spectrum beta-lactamase inhibitors: structure-based design, synthesis, and biological activity.
    Plantan I; Selic L; Mesar T; Anderluh PS; Oblak M; Prezelj A; Hesse L; Andrejasic M; Vilar M; Turk D; Kocijan A; Prevec T; Vilfan G; Kocjan D; Copar A; Urleb U; Solmajer T
    J Med Chem; 2007 Aug; 50(17):4113-21. PubMed ID: 17665896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of turnover of cefotaxime by the Enterobacter cloacae P99 and GCl beta-lactamases: two free enzyme forms of the P99 beta-lactamase detected by a combination of pre- and post-steady state kinetics.
    Kumar S; Adediran SA; Nukaga M; Pratt RF
    Biochemistry; 2004 Mar; 43(9):2664-72. PubMed ID: 14992604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different transition-state structures for the reactions of beta-lactams and analogous beta-sultams with serine beta-lactamases.
    Tsang WY; Ahmed N; Hinchliffe PS; Wood JM; Harding LP; Laws AP; Page MI
    J Am Chem Soc; 2005 Dec; 127(49):17556-64. PubMed ID: 16332108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toward better antibiotics: crystallographic studies of a novel class of DD-peptidase/beta-lactamase inhibitors.
    Silvaggi NR; Kaur K; Adediran SA; Pratt RF; Kelly JA
    Biochemistry; 2004 Jun; 43(22):7046-53. PubMed ID: 15170342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity relationship of 6-methylidene penems bearing 6,5 bicyclic heterocycles as broad-spectrum beta-lactamase inhibitors: evidence for 1,4-thiazepine intermediates with C7 R stereochemistry by computational methods.
    Venkatesan AM; Agarwal A; Abe T; Ushirogochi H; Yamamura I; Ado M; Tsuyoshi T; Dos Santos O; Gu Y; Sum FW; Li Z; Francisco G; Lin YI; Petersen PJ; Yang Y; Kumagai T; Weiss WJ; Shlaes DM; Knox JR; Mansour TS
    J Med Chem; 2006 Jul; 49(15):4623-37. PubMed ID: 16854068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of class A and class C beta-lactamases by penems: crystallographic structures of a novel 1,4-thiazepine intermediate.
    Nukaga M; Abe T; Venkatesan AM; Mansour TS; Bonomo RA; Knox JR
    Biochemistry; 2003 Nov; 42(45):13152-9. PubMed ID: 14609325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thermodynamic evaluation of a covalently bonded transition state analogue inhibitor: inhibition of beta-lactamases by phosphonates.
    Nagarajan R; Pratt RF
    Biochemistry; 2004 Aug; 43(30):9664-73. PubMed ID: 15274621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural basis for the extended substrate spectrum of CMY-10, a plasmid-encoded class C beta-lactamase.
    Kim JY; Jung HI; An YJ; Lee JH; Kim SJ; Jeong SH; Lee KJ; Suh PG; Lee HS; Lee SH; Cha SS
    Mol Microbiol; 2006 May; 60(4):907-16. PubMed ID: 16677302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relative catalytic efficiency of beta-lactamase catalyzed acyl and phosphyl transfer.
    Slater MJ; Laws AP; Page MI
    Bioorg Chem; 2001 Apr; 29(2):77-95. PubMed ID: 11300697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitors of metallo-beta-lactamase generated from beta-lactam antibiotics.
    Badarau A; LlinĂ¡s A; Laws AP; Damblon C; Page MI
    Biochemistry; 2005 Jun; 44(24):8578-89. PubMed ID: 15952764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorescein-labeled beta-lactamase mutant for high-throughput screening of bacterial beta-lactamases against beta-lactam antibiotics.
    Chan PH; Chan KC; Liu HB; Chung WH; Leung YC; Wong KY
    Anal Chem; 2005 Aug; 77(16):5268-76. PubMed ID: 16097768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetic and structural consequences of the leaving group in substrates of a class C beta-lactamase.
    Ahn YM; Pratt RF
    Bioorg Med Chem; 2004 Mar; 12(6):1537-42. PubMed ID: 15018927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-activity relationship of 6-methylidene penems bearing tricyclic heterocycles as broad-spectrum beta-lactamase inhibitors: crystallographic structures show unexpected binding of 1,4-thiazepine intermediates.
    Venkatesan AM; Gu Y; Dos Santos O; Abe T; Agarwal A; Yang Y; Petersen PJ; Weiss WJ; Mansour TS; Nukaga M; Hujer AM; Bonomo RA; Knox JR
    J Med Chem; 2004 Dec; 47(26):6556-68. PubMed ID: 15588091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-ketophosphonates as beta-lactamase inhibitors: Intramolecular cooperativity between the hydrophobic subsites of a class D beta-lactamase.
    Perumal SK; Adediran SA; Pratt RF
    Bioorg Med Chem; 2008 Jul; 16(14):6987-94. PubMed ID: 18572409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.